Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
05/09/1989 | CA1253997A1 Process for purifying growth hormone-like materials |
05/09/1989 | CA1253856A1 Brain-specific drug delivery |
05/09/1989 | CA1253816A1 Monoclonal antibodies against alveolar surfactant protein |
05/09/1989 | CA1253800A1 Human suppressor factor(s) and method |
05/05/1989 | WO1989003996A1 Human gamma, delta t cell antigen receptor polypeptides and nucleic acids |
05/05/1989 | WO1989003993A1 Paired helical filament core and antibody thereto useful in diagnosing alzheimer's disease |
05/05/1989 | WO1989003887A1 A process for the production of biologically active peptide via the expression of modified storage seed protein genes in transgenic plants |
05/05/1989 | WO1989003886A1 Expression systems for preparation of polypeptides in prokaryotic cells |
05/05/1989 | WO1989003884A1 Interleukin-7 |
05/05/1989 | WO1989003883A1 Enhancement of cell growth by expression of a cloned hemoglobin gene |
05/05/1989 | WO1989003881A1 Nonglycosylated analogs of human colony stimulating factors |
05/05/1989 | WO1989003880A1 A gene coding for glucuronide permease |
05/05/1989 | WO1989003878A1 Defective recombinant gene which can be activated by a transactivator |
05/05/1989 | WO1989003874A1 Novel polypeptide compounds |
05/05/1989 | WO1989003873A1 Regulation of cell proliferation and differentiation using peptides |
05/05/1989 | WO1989003872A1 Generation of neural precursor cell lines |
05/05/1989 | WO1989003849A1 Oligonucleotide-polyamide conjugates |
05/05/1989 | WO1989003846A2 Monoclonal antibodies against human interleukin-4 and hybridomas producing the same |
05/05/1989 | WO1989003845A1 Ps2 protein derivative |
05/05/1989 | WO1989003844A1 Hiv peptides, artificial hiv antigens and immunoassay kits |
05/05/1989 | WO1989003842A1 Renin inhibitors containing a (1-amino-2-hydroxy-2-heterocyclic) ethyl moiety |
05/05/1989 | WO1989003841A1 Renin inhibitors, processes for preparing them, methods for using them, and compositions containing them |
05/05/1989 | WO1989003840A1 Method of purifying protein |
05/05/1989 | WO1989003836A1 Factors associated with essential hypertension |
05/05/1989 | WO1989003813A1 Anti-retroviral agent |
05/05/1989 | WO1989003690A1 Application of dinitro-trinitrophenyl and its derivatives or of anti-nitrophenyl antibodies to the modification of the interaction between the target cellules of a host and a pathogenic agent |
05/05/1989 | WO1989003687A1 Composition and method for treating cancers characterized by over-expression of the c-fms proto-oncogene |
05/05/1989 | WO1989003686A1 Cgrp for cerebral blood supply improvement |
05/05/1989 | WO1989003680A1 Conjugates between a drug and a nitrophenyl group and their pharmaceutical application |
05/03/1989 | EP0314580A1 Use of nitrophenyl groups for stimulating the capability of incorporation of a drug into the sensitive cells of a host |
05/03/1989 | EP0314576A1 Tetra and pentapeptides with the sequence lysyl-arginyl-aspartyl, and their use as antithrombotics |
05/03/1989 | EP0314569A1 Recombinant fowlpox virus, expression vectors for heterologous proteins, and vaccines for fowl derived from this virus |
05/03/1989 | EP0314534A1 Expression vector for proteins from the HIV-2 virus, one of the agents that cause AIDS |
05/03/1989 | EP0314415A2 Interleukin-7 |
05/03/1989 | EP0314402A2 Monoclonal antibodies against human interleukin-4 and hybridomas producing the same |
05/03/1989 | EP0314317A1 Adheson variants, nucleic acid encoding them and compositions comprising them |
05/03/1989 | EP0314240A2 Process for purifying recombinant hepatitis antigens |
05/03/1989 | EP0314239A2 Tripeptide renin inhibitors with N-terminal ureido or sulfamido groups |
05/03/1989 | EP0314224A1 Vaccine against E.coli septicaemia in poultry |
05/03/1989 | EP0314202A1 The isolation of mRNA |
05/03/1989 | EP0314184A1 Expression plasmids |
05/03/1989 | EP0314127A2 Heterobifunctional coupling agents |
05/03/1989 | EP0314095A1 Plasma and recombinant protein formulation in high ionic strength media |
05/03/1989 | EP0314094A2 Recombinant lymphotoxin |
05/03/1989 | EP0314060A2 Renin inhibitors, processes for preparing them, methods for using them, and compositions containing them |
05/03/1989 | EP0314023A2 Peptides containing glutamine, process for their preparation and their use |
05/03/1989 | EP0313969A2 Tripeptide derivatives and antiplasmin agents containing the same |
05/03/1989 | EP0313874A2 Disulfur analogs of LL-E33288 antitumor agents |
05/03/1989 | EP0313873A1 Targeted forms of methyltrithio antitumor agents |
05/03/1989 | EP0313641A1 Activation antigen |
05/03/1989 | DE3833897A1 Klonierung und expression des transforming growth faktor-(beta)2 Cloning and expression of transforming growth factor (beta) 2 |
05/03/1989 | CN1032661A Method of purifying protein |
05/02/1989 | US4826957 Immunogenic recombinant yeast expression product and method for purifying it |
05/02/1989 | US4826814 Inhibitors of angiotensin converting enzyme |
05/02/1989 | US4826813 4'-Methyl-β-mercapto-β,β-cyclopentamethylenepropionic acid vasopressin antagonists |
05/02/1989 | US4826811 Crosslinked, pyridoxylated hemoglobin free of tetramers |
05/02/1989 | US4826765 Yeast strains genetically engineered to produce wheat gluten proteins |
05/02/1989 | US4826764 Enhancing the translational initiation frequency of a gene |
05/02/1989 | US4826763 Genetically transformed saccharomyces |
04/26/1989 | EP0313515A1 A polypeptide growth factor from milk |
04/26/1989 | EP0313377A1 Process for purification of soluble T4 |
04/26/1989 | EP0313343A1 Method of purifying protein |
04/26/1989 | EP0313333A2 Bacterial strain |
04/26/1989 | EP0313224A1 Human cell lines of epithelial lung adenocarcinoma origin, human proteins and methods |
04/26/1989 | EP0313158A2 Gastrin releasing peptide antagonist |
04/26/1989 | EP0313156A1 SnRNP-A antigen and fragments thereof |
04/26/1989 | EP0313104A2 Purification, production and use of tumor necrosis factors |
04/26/1989 | EP0313009A2 Method of gene amplification for enhancing protein production in cultured animal cells |
04/26/1989 | EP0312963A2 Modification method for peptides and proteins |
04/26/1989 | EP0312942A2 Polypeptides with a prourokinase activity, their production and use |
04/26/1989 | EP0312941A2 Polypeptides with a prourokinase activity, their production and use |
04/26/1989 | EP0312898A2 Phenylacetylglutamine (pag) analytical test |
04/26/1989 | EP0312645A1 Antigenic peptides from complement factor C3a, use of peptides, cell lines, antibodies against the peptides and utilisation of the antibodies |
04/26/1989 | EP0312598A1 Peptide functioning to accelerate activation of protein c with thrombin |
04/25/1989 | US4824986 Diethylenetriaminepentaacetic acid substituted with isothiocyanate or n-hydroxysuccinimide |
04/25/1989 | US4824938 Stabilized by maltose-containing polysaccharides |
04/25/1989 | US4824937 Synthetic natriuretic peptides |
04/25/1989 | US4824936 (19-Alanine) calcitonin |
04/25/1989 | US4824850 Dihydropyridine-pyridinium salt redox carrier |
04/25/1989 | US4824659 Antibody conjugates |
04/25/1989 | CA1253299A1 Polypeptide and process for producing the same |
04/25/1989 | CA1253298A1 Synthetic picornavirus antigen |
04/25/1989 | CA1253093A1 Rabies vaccine and preparation process thereof |
04/25/1989 | CA1253092A1 Derivative of the tryptophan operon for expression of fused gene products |
04/25/1989 | CA1253073A1 Antigenic preparations and isolation of such preparations |
04/25/1989 | CA1253071A1 Use of transforming growth factor to promote wound healing |
04/25/1989 | CA1253069A1 Synthetic hepatitis b virus vaccine including both t cell and b cell determinants |
04/24/1989 | EP0302925A4 A method for producing factor viii in high yield. |
04/24/1989 | EP0241539A4 Expression systems for overproduction of desired proteins. |
04/20/1989 | WO1989003532A1 Means for diagnosing arc and aids |
04/20/1989 | WO1989003429A1 Recombinant avipox virus |
04/20/1989 | WO1989003427A1 A method of maintaining a desired recombinant gene in a genetic population of cells |
04/20/1989 | WO1989003423A1 Synthetic dna sequence coding for human insulin-like growth factor ii |
04/20/1989 | WO1989003422A1 Synthetic gene |
04/20/1989 | WO1989003420A1 Anti-retroviral agent |
04/20/1989 | WO1989003399A1 Method of preparation and use for zona pellucida antigens and antibodies for sterilization and contraception |
04/20/1989 | WO1989003398A1 Human monoclonal antibody against candida |
04/20/1989 | WO1989003396A2 Antibodies to natural killer cell and non-specific cytotoxic cell receptor |
04/20/1989 | WO1989003395A1 Receptor for natural killer and non-specific cytotoxic cells |
04/20/1989 | WO1989003394A1 Antigen recognized by natural killer and non-specific cytotoxic cells |